Ingrid Goldberg | ABIOMED, Inc. |
Michael R. Minogue | ABIOMED, Inc. |
Todd A. Trapp | ABIOMED, Inc. |
Chris Pasquale | Guggenheim Securities LLC |
Jayson T. Bedford | Raymond James & Associates, Inc. |
Bruce M. Nudell | SunTrust Robinson Humphrey, Inc. |
Raj Denhoy | Jefferies LLC |
Isaac Ro | Goldman Sachs & Co. LLC |
Margaret M. Kaczor | William Blair & Co. LLC |
Matthew O'Brien | Piper Jaffray & Co. |
Danielle Antalffy | Leerink Partners LLC |
Jaypreet S Chadha | Morgan Stanley & Co. LLC |
Good day, ladies and gentlemen, and welcome to the Q2 Fiscal Year 2019 Abiomed, Incorporated Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this conference call may be recorded. I would now like to introduce your host for today's conference, Mr.